Luleze Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream is effective against a broad spectrum of dermatophytes such as Trichophyton rubrum, Trichophyton mentagrophytes, and Candida species. Luleze Cream is applied once daily to the affected area and surrounding skin after cleansing and drying, typically for a duration of 1 to 2 weeks depending on the type and severity of infection. It is well tolerated with minimal local adverse effects, which may include mild burning, itching, or irritation at the application site. The cream should not be used on mucous membranes or broken skin, and patients should avoid contact with eyes. Luleze Cream offers a convenient and effective topical treatment option for fungal skin infections, promoting rapid symptom relief and resolution of infection when used as directed. Patients are advised to complete the full course of therapy to prevent recurrence.